• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and Steatosis.铁伴侣蛋白聚 rC 结合蛋白 1 可保护小鼠肝脏免受脂质过氧化和脂肪变性。
Hepatology. 2021 Mar;73(3):1176-1193. doi: 10.1002/hep.31328. Epub 2020 Nov 3.
2
Mitochondrial dysfunction in mouse livers depleted of iron chaperone PCBP1.PCBP1 耗竭导致小鼠肝脏线粒体功能障碍。
Free Radic Biol Med. 2021 Nov 1;175:18-27. doi: 10.1016/j.freeradbiomed.2021.08.232. Epub 2021 Aug 26.
3
The iron chaperone and nucleic acid-binding activities of poly(rC)-binding protein 1 are separable and independently essential.多聚(rC)结合蛋白 1 的铁伴侣和核酸结合活性是可分离的,并且独立地是必需的。
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25). doi: 10.1073/pnas.2104666118.
4
Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.聚(rC)结合蛋白 1 抑制头颈部癌症中铁蛋白自噬介导的铁死亡。
Redox Biol. 2022 May;51:102276. doi: 10.1016/j.redox.2022.102276. Epub 2022 Mar 9.
5
ECM1 protects against liver steatosis through PCBP1-mediated iron homeostasis.细胞外基质蛋白1通过聚(C)结合蛋白1介导的铁稳态来预防肝脏脂肪变性。
Hepatology. 2025 May 15. doi: 10.1097/HEP.0000000000001402.
6
The iron chaperone poly(rC)-binding protein 1 regulates iron efflux through intestinal ferroportin in mice.铁伴侣蛋白 poly(rC)-结合蛋白 1 通过调控肠道亚铁转运蛋白 ferroportin 实现铁外排。
Blood. 2023 Nov 9;142(19):1658-1671. doi: 10.1182/blood.2023020504.
7
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.肝特异性β-catenin 缺失的小鼠在铁过载后会发生脂肪性肝炎和肝纤维化。
J Hepatol. 2017 Aug;67(2):360-369. doi: 10.1016/j.jhep.2017.03.012. Epub 2017 Mar 22.
8
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3.人类肝脂肪变性中的脂质过氧化与肝纤维化相关,且主要发生在腺泡3区。
J Gastroenterol Hepatol. 2001 Jun;16(6):599-606. doi: 10.1046/j.1440-1746.2001.02445.x.
9
Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.铁伴侣蛋白 PCBP1 和 PCBP2 介导二核铁酶脱羟鸟氨酸羟化酶的金属化。
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8031-6. doi: 10.1073/pnas.1402732111. Epub 2014 May 19.
10
TBBPA induced hepatocyte ferroptosis by PCBP1-mediated ferritinophagy.四溴双酚A通过PCBP1介导的铁自噬诱导肝细胞铁死亡。
J Hazard Mater. 2025 Aug 15;494:138515. doi: 10.1016/j.jhazmat.2025.138515. Epub 2025 May 6.

引用本文的文献

1
Unlocking longevity through the comparative biology of aging.通过衰老的比较生物学解锁长寿之道。
Nat Aging. 2025 Aug 28. doi: 10.1038/s43587-025-00945-8.
2
Oxidative Ferritin Destruction: A Key Mechanism of Iron Overload in Acetaminophen-Induced Hepatocyte Ferroptosis.氧化型铁蛋白破坏:对乙酰氨基酚诱导的肝细胞铁死亡中铁过载的关键机制
Int J Mol Sci. 2025 Aug 5;26(15):7585. doi: 10.3390/ijms26157585.
3
Ferroptosis and bone health: bridging the gap between mechanisms and therapy.铁死亡与骨骼健康:弥合机制与治疗之间的差距
Front Immunol. 2025 Jul 16;16:1634516. doi: 10.3389/fimmu.2025.1634516. eCollection 2025.
4
MicroRNAs at the crossroads of exercise and ferroptosis: a regulatory bridge.运动与铁死亡交叉点上的微小RNA:一座调控桥梁
Clin Exp Med. 2025 Jul 6;25(1):234. doi: 10.1007/s10238-025-01766-0.
5
Acteoside ameliorates hepatocyte ferroptosis and hepatic ischemia-reperfusion injury targeting PCBP2.毛蕊花糖苷通过靶向PCBP2改善肝细胞铁死亡和肝缺血再灌注损伤。
Acta Pharm Sin B. 2025 Apr;15(4):2077-2094. doi: 10.1016/j.apsb.2025.03.002. Epub 2025 Mar 7.
6
Dysregulation of Labile Iron Predisposes Chemotherapy Resistant Cancer Cells to Ferroptosis.不稳定铁的失调使化疗耐药癌细胞易发生铁死亡。
Int J Mol Sci. 2025 Apr 28;26(9):4193. doi: 10.3390/ijms26094193.
7
Iron Metabolism and Muscle Aging: Where Ferritinophagy Meets Mitochondrial Quality Control.铁代谢与肌肉衰老:铁蛋白自噬与线粒体质量控制的交汇点
Cells. 2025 May 3;14(9):672. doi: 10.3390/cells14090672.
8
Transferrin receptors.转铁蛋白受体
Exp Mol Med. 2025 Apr;57(4):724-732. doi: 10.1038/s12276-025-01436-x. Epub 2025 Apr 22.
9
Ferroptosis as a key player in the pathogenesis and intervention therapy in liver injury: focusing on drug-induced hepatotoxicity.铁死亡在肝损伤发病机制及干预治疗中的关键作用:聚焦药物性肝毒性
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 17. doi: 10.1007/s00210-025-04115-w.
10
Epigenetic modifications of nuclear and mitochondrial DNA are associated with the disturbance of serum iron biomarkers among the metabolically unhealthy obesity school-age children.核DNA和线粒体DNA的表观遗传修饰与代谢不健康的肥胖学龄儿童血清铁生物标志物的紊乱有关。
Nutr J. 2025 Apr 2;24(1):51. doi: 10.1186/s12937-025-01108-6.

铁伴侣蛋白聚 rC 结合蛋白 1 可保护小鼠肝脏免受脂质过氧化和脂肪变性。

Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and Steatosis.

机构信息

Genetics and Metabolism SectionNIDDK, NIHBethesdaMD.

Mouse Metabolism CoreNIDDK, NIHBethesdaMD.

出版信息

Hepatology. 2021 Mar;73(3):1176-1193. doi: 10.1002/hep.31328. Epub 2020 Nov 3.

DOI:10.1002/hep.31328
PMID:32438524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8364740/
Abstract

BACKGROUND AND AIMS

Iron is essential yet also highly chemically reactive and potentially toxic. The mechanisms that allow cells to use iron safely are not clear; defects in iron management are a causative factor in the cell-death pathway known as ferroptosis. Poly rC binding protein 1 (PCBP1) is a multifunctional protein that serves as a cytosolic iron chaperone, binding and transferring iron to recipient proteins in mammalian cells. Although PCBP1 distributes iron in cells, its role in managing iron in mammalian tissues remains open for study. The liver is highly specialized for iron uptake, utilization, storage, and secretion.

APPROACH AND RESULTS

Mice lacking PCBP1 in hepatocytes exhibited defects in liver iron homeostasis with low levels of liver iron, reduced activity of iron enzymes, and misregulation of the cell-autonomous iron regulatory system. These mice spontaneously developed liver disease with hepatic steatosis, inflammation, and degeneration. Transcriptome analysis indicated activation of lipid biosynthetic and oxidative-stress response pathways, including the antiferroptotic mediator, glutathione peroxidase type 4. Although PCBP1-deleted livers were iron deficient, dietary iron supplementation did not prevent steatosis; instead, dietary iron restriction and antioxidant therapy with vitamin E prevented liver disease. PCBP1-deleted hepatocytes exhibited increased labile iron and production of reactive oxygen species (ROS), were hypersensitive to iron and pro-oxidants, and accumulated oxidatively damaged lipids because of the reactivity of unchaperoned iron.

CONCLUSIONS

Unchaperoned iron in PCBP1-deleted mouse hepatocytes leads to production of ROS, resulting in lipid peroxidation (LPO) and steatosis in the absence of iron overload. The iron chaperone activity of PCBP1 is therefore critical for limiting the toxicity of cytosolic iron and may be a key factor in preventing the LPO that triggers the ferroptotic cell-death pathway.

摘要

背景与目的

铁是生命所必需的,但同时也具有很高的化学反应活性和潜在的毒性。细胞安全利用铁的机制尚不清楚;铁代谢缺陷是细胞死亡途径(即铁死亡)的一个致病因素。多聚 rC 结合蛋白 1(PCBP1)是一种多功能蛋白,作为细胞质铁伴侣蛋白,在哺乳动物细胞中结合并将铁传递给受体蛋白。虽然 PCBP1 在细胞内分配铁,但它在哺乳动物组织中管理铁的作用仍有待研究。肝脏是专门用于铁摄取、利用、储存和分泌的器官。

方法和结果

肝细胞中缺乏 PCBP1 的小鼠表现出肝脏铁稳态缺陷,肝铁含量低,铁酶活性降低,细胞自主铁调节系统失调。这些小鼠自发发生肝脏疾病,伴有肝脂肪变性、炎症和变性。转录组分析表明,脂质生物合成和氧化应激反应途径被激活,包括抗铁死亡介质谷胱甘肽过氧化物酶 4。尽管 PCBP1 缺失的肝脏缺铁,但饮食中铁的补充并不能预防脂肪变性;相反,饮食中铁限制和维生素 E 的抗氧化治疗可以预防肝脏疾病。PCBP1 缺失的肝细胞表现出不稳定铁的增加和活性氧(ROS)的产生,对铁和促氧化剂敏感,并且由于无伴侣铁的反应性而积累氧化损伤的脂质。

结论

PCBP1 缺失的小鼠肝细胞中未被伴侣蛋白结合的铁导致 ROS 的产生,从而导致在没有铁过载的情况下发生脂质过氧化(LPO)和脂肪变性。因此,PCBP1 的铁伴侣活性对于限制细胞质铁的毒性至关重要,并且可能是防止触发铁死亡细胞死亡途径的 LPO 的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/7d86b306db98/nihms-1731957-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/91b71ff72fcc/nihms-1731957-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/75b2a5ae6085/nihms-1731957-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/6e93072ddc46/nihms-1731957-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/4a02b91af6bf/nihms-1731957-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/c0d4f21c93c8/nihms-1731957-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/a9467ad1e42f/nihms-1731957-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/7d86b306db98/nihms-1731957-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/91b71ff72fcc/nihms-1731957-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/75b2a5ae6085/nihms-1731957-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/6e93072ddc46/nihms-1731957-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/4a02b91af6bf/nihms-1731957-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/c0d4f21c93c8/nihms-1731957-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/a9467ad1e42f/nihms-1731957-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/8364740/7d86b306db98/nihms-1731957-f0007.jpg